Concerns about Prescribing Opioids

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
In this video, Bruce Stark, MD, of Providence Saint Joseph Medical Center in Burbank, California, talks about the importance of choosing patients properly and screening for substance abuse disorders before prescribing or dispensing opioids.

Related Articles
The FDA today approved AstraZeneca’s naloxegol (Movantik) treatment for opioid-induced constipation in adults with chronic noncancer pain.
Through the Pharmacist Connect program, pharmacists from chain member companies provided 2014 NACDS Total Store Expo attendees with immunizations and other pharmacy services.
Although many pharmacists express concerns about the state of the pharmacy job market, the good news is the demand for pharmacists seems to be increasing.
In several countries, increases in the incidence of inflammatory bowel disease have been observed closely following regulatory approval of sucralose.
Latest Issues
$auto_registration$